Quantitative research platform for building and testing systematic trading strategies with point-in-time backtests and walk-forward validation
AI-powered stock screener and backtesting platform for US equity traders
Stage
Startup
Not given
Founded
2025
Not given
Based in
DE
Not given
Pricing model
Freemium
Freemium
Pricing
Starter €7.99/month, Practitioner €19.50/month (regularly €39), Research €34.50/month (regularly €69). All prices include VAT. Every new account gets 30 days of Practitioner free with no card required.
Not given
Key features
Visual strategy builder with circuit diagram interface
Point-in-time backtesting over 20 years of history
Walk-forward validation and robustness testing
Indicator strategies with mean reversion and momentum
Stochastic methods including Kalman filter and Ornstein-Uhlenbeck models
Factor model and portfolio construction tools
Paper trading with daily marked prices
Python code export for backtests and strategies
Regime analysis and market regime detection
Stock screener with technical and fundamental filters
Screener backtesting with historical win rates and drawdowns
Watchlists for tracking stocks
Real-time market news with sentiment analysis
Sector heatmap showing rotation and performance
Economic and corporate event calendar
Seasonality patterns with historical frequency analysis
Chart pattern recognition
AI-powered Dr. Market assistant with real data feeds
What makes it different
Point-in-time data discipline prevents look-ahead bias and ensures strategies see only information available on each date
113 published research articles and studies with reproducible methodology and full audit trail
Circuit diagram interface makes strategy design accessible without requiring extensive coding
Full Python export enables strategies to be deployed outside the platform
AI analysis based only on real market data feeds, never generating numbers from memory
All-in-one trading ecosystem consolidating screening, news, charts, and analysis
Backtesting with complete drawdown visibility alongside win rates
Direct founder support without ticket maze
Analysis tool for validating theses, not investment advice service